BBVA
SIOX

Banco Bilbao Vizcaya Argentaria’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50,000
Closed -$141K – 786
2020
Q2 		$141K Buy
+50,000
New +$160K ﹤0.01% 729

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's SIOX Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2020, closing a stake of 50,000 shares — an estimated $141K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in SIOX in Q2 2020 and held it in 1 quarter. The position peaked at $141K in Q2 2020. 50 funds tracked by Wall St. Rank hold SIOX as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 50,000 Sio Gene Therapies Inc. Common Stock shares in Q3 2020, an estimated $141K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Sio Gene Therapies Inc. Common Stock position peaked at $141K in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.